CBAY - Cymabay Therapeu - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Cymabay Therapeu's activity chart (see below) currently has 145 price targets and 138 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 88.33% with an average time for these price targets to be met of 803.27 days.

Most recent stock forecast was given by from WESTPARK on 29-Feb-2024.

Best performing analysts who are covering CBAY - Cymabay Therapeu:

Eliana Merle Pasha Sarraf Edward Nash Yasmeen Rahimi Derek Archila

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 29-Feb-2024

$32.5

$0.02 (0.06%)

Buy Since 12-May-2020

$32.5

$0.02 (0.06%)

$12

Buy Since 12-May-2020

$32.5

$0.02 (0.06%)

$25

Show more analysts

Please expand the browser size to see the chart

What is CBAY (Cymabay Therapeu) average time for price targets to be met?

On average it took 803.27 days on average for the stock forecasts to be realized with a an average price target met ratio 88.33

Which analyst has the current highest performing score on CBAY (Cymabay Therapeu) with a proven track record?

ELIANA MERLE

Which analyst has the most public recommendations on CBAY (Cymabay Therapeu)?

Eliana Merle works at BARCLAYS and has 21 price targets and 18 ratings on CBAY

Which analyst is the currently most bullish on CBAY (Cymabay Therapeu)?

Eliana Merle with highest potential upside - $0.02

Which analyst is the currently most reserved on CBAY (Cymabay Therapeu)?

Joel Beatty with lowest potential downside - -$22.48

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?